Company intelligence / Profile preview

OBELAB

Gangnam-gu, Seoul, South Koreaobelab.com ↗

Ownership: Private
Development stage: Commercial

Overview

OBELAB has commercialized high-resolution portable brain imaging devices based on fNIRS technology. Their flagship product NIRSIT is used by hospitals and research institutions worldwide for non-invasive brain function monitoring. The company has achieved regulatory approvals including KFDA in Korea and CE marking in Europe. Clinical results cited include use of their device to monitor changes in prefrontal cortex activity during interventions, supporting its utility for both clinical trials and cognitive neuroscience studies.

Therapeutic areas: Neurology
Modalities: Device
Industry: Medical Imaging

Partnerships

No major pharmaceutical or biotech partnerships publicly disclosed; collaborates with academic/research institutions globally

Beyond the preview

Go deeper on OBELAB.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OBELAB.

Explore the full profile